With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.
Viral vectors and vaccines navigate public distrust while advancing through AI design, COVID response lessons, and promising ...
News Medical on MSN
UVA Health scientists pioneer a new way to create vaccines far more quickly than ever before
UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly ...
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
Moderna, Inc. vs. Novavax, Inc.: cost cuts, vaccine pipeline catalysts, and valuations. Click for this comparison of NVAX and ...
The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...
Verndari is one of four companies selected by BARDA to develop alternative vaccine delivery technologies for existing and emerging infectious diseases. Verndari’s VaxiPatch™ technology shows ...
“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries indicate that ...
This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...
Seeking to build domestic vaccine manufacturing capacity, the Philippine government is moving to reduce reliance on imported ...
VANCOUVER, BC and MADISON, Wis., Oct. 14, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to announce that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results